Literature DB >> 25096916

Relapse post hematopoietic SCT remains the Achilles heel for the field.

H Frangoul1, M Jagasia2.   

Abstract

Mesh：

Year:  2014        PMID： 25096916     DOI： 10.1038/bmt.2014.134

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  21 in total

Review 1.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

Review 2.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

3.  Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

Authors:  A Spyridonidis; M Labopin; C Schmid; L Volin; I Yakoub-Agha; M Stadler; N Milpied; G Socie; P Browne; S Lenhoff; M A Sanz; M Aljurf; M Mohty; V Rocha
Journal:  Leukemia       Date:  2012-01-31       Impact factor: 11.528

4.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

5.  Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Authors:  M Eapen; S A Giralt; M M Horowitz; J P Klein; J E Wagner; M-J Zhang; M S Tallman; D I Marks; B M Camitta; R E Champlin; O Ringdén; C N Bredeson; R Martino; R P Gale; M S Cairo; M R Litzow; M deLima
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

6.  Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation.

Authors:  Saiko Kurosawa; Takahiro Fukuda; Kinuko Tajima; Bungo Saito; Shigeo Fuji; Hiroki Yokoyama; Sung-Won Kim; Shin-Ichiro Mori; Ryuji Tanosaki; Yuji Heike; Yoichi Takaue
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

Review 7.  Relapse after allogeneic hematopoietic cell therapy.

Authors:  Marcel R M van den Brink; David L Porter; Sergio Giralt; Sydney X Lu; Robert R Jenq; Alan Hanash; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-24       Impact factor: 5.742

8.  Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies.

Authors:  R Bajwa; T Schechter; S Soni; A Gassas; J Doyle; I Sisler; K Godder; D Tatman; S Rumelhart; J Domm; Y Miao; H Frangoul
Journal:  Bone Marrow Transplant       Date:  2012-11-05       Impact factor: 5.483

9.  CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.

Authors:  Renier J Brentjens; Marco L Davila; Isabelle Riviere; Jae Park; Xiuyan Wang; Lindsay G Cowell; Shirley Bartido; Jolanta Stefanski; Clare Taylor; Malgorzata Olszewska; Oriana Borquez-Ojeda; Jinrong Qu; Teresa Wasielewska; Qing He; Yvette Bernal; Ivelise V Rijo; Cyrus Hedvat; Rachel Kobos; Kevin Curran; Peter Steinherz; Joseph Jurcic; Todd Rosenblat; Peter Maslak; Mark Frattini; Michel Sadelain
Journal:  Sci Transl Med       Date:  2013-03-20       Impact factor: 17.956

10.  Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.

Authors:  Britta Eiz-Vesper; Britta Maecker-Kolhoff; Rainer Blasczyk
Journal:  Front Immunol       Date:  2013-01-28       Impact factor: 7.561
View more
  1 in total

1.  Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing.

Authors:  Andi Wang; Wenjun Li; Fei Zhao; Zhongzheng Zheng; Ting Yang; Sanbin Wang; Jinsong Yan; Jianpin Lan; Shengjin Fan; Mingfeng Zhao; Jianpin Shen; Xin Li; Tonghua Yang; Quanyi Lu; Ying Lu; Hai Bai; Haiyan Zhang; Dali Cai; Ling Wang; Zhiyang Yuan; Erlie Jiang; Fang Zhou; Xianmin Song
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.